Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
07/1995
07/19/1995CN1105360A 1-|2H-1-benzopyran-2-one-8yl¨-piperazin derivative
07/19/1995CN1105358A N-substituted azabicycloheptane derivatives, the preparation and use thereof
07/19/1995CN1105234A Hair coloring composition
07/18/1995US5434146 Antitumor, breast cancer
07/12/1995EP0662004A1 Use of persistent free-radicals in magnetic resonance imaging
07/11/1995US5432166 Use of 1-(β-D-arabinofuranosyl) -5-propynyluracil for lowering serum cholesterol
07/11/1995US5432165 Methods for the treatment of infection caused by Hepatitis B virus (HBV)
07/11/1995US5432164 C2,N6 -disubstituted adenosine derivatives
07/11/1995US5431902 New medicament aerosol formulation based on fusafungine
07/11/1995CA1336264C Pharmaceutical compositions containing deoxyribonucleosides for wound healing
07/11/1995CA1336262C Mycoplasma vaccine
07/06/1995WO1995017875A2 MIXTURES OF DIDEOXYNUCLEOSIDES AND D-ASPARTIC ACID β-HYDROXAMATE FOR INHIBITING RETROVIRAL SPREAD
07/05/1995EP0660719A1 Method and composition for ameliorating tissue damage due to ischemia and reperfusion
07/05/1995EP0660710A1 Compositions of n-(phosphonoacetyl)-l-aspartic acid and methods of their use as broad spectrum antivirals
07/05/1995EP0660699A1 Hair relaxer compositions
07/05/1995EP0328634B1 Pharmaceutical compositions for the treatment of psoriasis
07/04/1995US5430041 Amino acid derivatives having antiviral activity
06/1995
06/29/1995WO1995017210A1 Vaccines
06/29/1995WO1995017209A1 Vaccines
06/29/1995WO1995017163A1 Skin cleaning composition
06/29/1995CA2179520A1 Skin cleaning composition
06/28/1995EP0659439A2 Immunoconjugates
06/28/1995EP0659410A2 Use of the compound flupirtin against muscle bracing
06/28/1995EP0460171B1 Cd3 specific recombinant antibody
06/27/1995US5428135 Production of platelet-derived growth factor B-chain heterodimers from high expression host cell system
06/22/1995WO1995010271A3 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
06/22/1995WO1995008318A3 Medicinal substance with anti-infection properties and for use in the treatment of infertility and protection of pregnancy
06/21/1995EP0658341A1 Cosmetic and dermatological compositions for the protection against UV radiation containing stilbene derivatives
06/21/1995EP0658093A1 Process and kit for dyeing hair
06/21/1995EP0458959B1 Novel platelet-derived growth factor b chain analogs and method for homogeneous production thereof
06/21/1995CN1028990C Hiv-inhibiting benzeneacetamide derivatives
06/14/1995EP0657166A1 Combination containing a quinoxaline and a nucleoside
06/14/1995EP0657029A1 Calcium receptor active molecules
06/14/1995EP0656781A1 Composition comprising fertilized shell eggs
06/10/1995CA2137605A1 Combination preparations comprising a quinoxaline and a nucleoside
06/08/1995WO1995015173A1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
06/08/1995WO1995015169A1 Use of dimeticone for treating aphthae and stomatitis
06/08/1995CA2177825A1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
06/07/1995EP0656213A1 Treatment of conditions and disease
06/07/1995EP0655918A1 Treatment of cancer with azt and alkylating or intercalating agents
06/07/1995EP0454783B1 Site specific in-vivo activation of therapeutic drugs
06/06/1995CA2044795C Dermatological composition based on an aqueous phase
05/1995
05/31/1995EP0655247A1 Use of vincristine for the evaluation of substances at the neuroral level
05/31/1995EP0655240A2 Immediate release tablet cores of insoluble drugs having substained-release coating
05/31/1995EP0655237A1 Medicinal aerosol formulation
05/31/1995EP0654998A1 METHOD OF NEUTRALIZING IL-1 USING dsRNAs
05/28/1995CA2136704A1 Medicinal aerosol formulation
05/26/1995WO1995013790A1 Non-irritating cosmetic compositions
05/26/1995WO1995013789A1 Cosmetic method for treatment of skin
05/26/1995CA2175812A1 Non-irritating cosmetic compositions
05/26/1995CA2175676A1 Cosmetic method for treatment of skin
05/24/1995EP0654263A1 Sustained release composition and a method of preparing pharmaceutical compositions
05/24/1995CN1028521C Therapeutic agents
05/23/1995US5418221 Composition containing enamel matrix from tooth germs for inducing binding between living mineralized tissue parts
05/17/1995EP0652872A1 Optically pure salts of pyridinylmethyl sulfinyl-1h-benzimidazole compounds
05/17/1995EP0652765A1 Des-tyr dynorphin analogues
05/17/1995EP0652743A1 Oral compositions.
05/17/1995EP0510158B1 Improved anti-plaque compositions comprising a combination of morpholinoamino alcohol and metal salts
05/16/1995US5415853 Compressed gas packages using polyoxyethylene glyceryl oleates
05/16/1995CA1335590C Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
05/10/1995EP0651793A1 Dna sequences used in the production of recombinant human bssl/cel in transgenic non-human mammals, and the produced bssl/cel used in infant formulas
05/10/1995EP0496835B1 Solid tumor treatment method and composition
05/09/1995US5413793 Treatment of hemorrhoids with drugs in silicone oils and multilayer elements
05/09/1995US5413572 Osmotic dosage system for liquid drug delivery
05/04/1995WO1995011688A1 Method for treating hepatitis b carriers with minimal disease
05/03/1995EP0650964A1 1 2H-1-benzopyran-2-one-8-yl -piperazine derivatives
05/03/1995EP0650496A1 Anti-inflammatory compounds for ophthalmic use
05/03/1995EP0650359A1 TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING THE ACTIVE SUBSTANCE 17-$g(b)-OESTRADIOL (ANHYDROUS)
05/03/1995EP0500605B1 Cosmetic deodorants
05/03/1995CA2134630A1 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives
05/02/1995US5411734 Cosmetics with ester compounds in mixtures
04/1995
04/27/1995WO1995011221A1 Calcium receptor-active arylalkyl amines
04/27/1995WO1995011030A1 Pharmaceutical formulations of aspirin and salicylates
04/27/1995WO1995011005A1 Skin-cleansing agents, methods of preparing them and their use
04/27/1995CA2173120A1 Skin-cleansing agents, methods of preparing them and their use
04/26/1995EP0649854A1 Bisconjugates comprising two saccharides and a spacer
04/25/1995US5409694 Liquid deodorant compositions
04/25/1995US5409640 Cleansing compositions
04/20/1995WO1995010271A2 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
04/20/1995CA2172960A1 Treatment of allergic disorders with terfenadine carboxylate
04/19/1995EP0648745A1 Arylalkylamine having anticonvulsant and neuroprotective properties
04/19/1995EP0648489A1 Arylalkylamides having neuroprotective properties
04/18/1995US5407922 Certain N-substituted-amino-alkane phosphinic acid derivatives having anti-epileptic properties
04/18/1995CA2041974C Cosmetic composition
04/18/1995CA2015475C Treating agent for osteoarthritis
04/18/1995CA1335267C Method for technetium/rhenium labeling of proteins
04/18/1995CA1335261C Fine-milled colestipol hydrochloride
04/13/1995WO1995009609A1 New emulsion formulation
04/13/1995DE4341139C1 Dimethicone for the treatment of aphthae
04/13/1995CA2172143A1 New emulsion formulation
04/12/1995EP0647231A1 N-substituted 3-azabicyclo 3.2.0]heptane derivates useful as neuroleptic agents, etc.
04/12/1995EP0647137A1 Glycine receptor antagonists and the use thereof
04/12/1995EP0594698B1 Liquid deodorant compositions
04/12/1995EP0502042B1 Pharmaceutical compositions
04/11/1995US5405854 Sulfonamidocarboxamides
04/11/1995US5405837 Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin
04/11/1995US5405605 Clear antiperspirant stick
04/06/1995WO1995008998A1 Compositions for the prevention and treatment of viral-induced tumors
04/06/1995DE4433990A1 Composition for foam baths, bath salts and/or shower gels
04/06/1995CA2172261A1 Compositions for the prevention and treatment of viral-induced tumors
1 ... 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 ... 295